Literature DB >> 29790004

Exploring sex-specific differences in the presentation and outcomes of ANCA-associated vasculitis: a nationwide registry-based cohort study.

Rune Bjørneklett1,2, Vilde Solbakken3, Leif Bostad4, Anne-Siri Fismen5.   

Abstract

PURPOSE: Sex-specific differences in the risk of end-stage renal disease (ESRD) in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) stratified by histological classification have not been previously investigated.
METHODS: Patients with biopsy-verified pauci-immune necrotizing GN and positive ANCA serology in the Norwegian Kidney Biopsy Registry between 1991 and 2012 were included. Patients with ESRD during follow-up were identified from the Norwegian Renal Registry. ESRD-free survival stratified by histological classifications was investigated.
RESULTS: We analyzed 358 patients, of whom 87 progressed to ESRD during follow-up. Overall ESRD-free survival at 1 and 5 years in the entire cohort was 81 and 71% in males versus 90 and 80% in females, respectively; 94 and 84% in males versus 98 and 98% in females with focal histology, respectively; 85 and 76% in males versus 89 and 77% in females with mixed histology, respectively; 72 and 58% in males versus 90 and 78% in females with crescentic histology, respectively; and 52 and 46% in males versus 60 and 38% in females with sclerotic histology, respectively. Males had an increased risk of ESRD (adjusted hazard ratio, 2.44 [1.56-3.82]; p < 0.001).
CONCLUSION: Male sex is associated with increased risk of ESRD across all histological classes of ANCA-GN.

Entities:  

Keywords:  ANCA-associated glomerulonephritis; ANCA-associated vasculitis; End-stage renal disease; Renal pathology

Mesh:

Year:  2018        PMID: 29790004     DOI: 10.1007/s11255-018-1888-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

1.  Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis.

Authors:  K Aasarød; L Bostad; J Hammerstrøm; S Jørstad; B M Iversen
Journal:  Nephrol Dial Transplant       Date:  2001-05       Impact factor: 5.992

2.  The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age.

Authors:  Anisha Tanna; Charles D Pusey
Journal:  J Rheumatol       Date:  2017-03       Impact factor: 4.666

Review 3.  ANCA Glomerulonephritis and Vasculitis.

Authors:  J Charles Jennette; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-25       Impact factor: 8.237

4.  Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.

Authors:  Rune Bjørneklett; Sanjeevan Sriskandarajah; Leif Bostad
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 8.237

5.  Histopathologic classification of ANCA-associated glomerulonephritis.

Authors:  Annelies E Berden; Franco Ferrario; E Christiaan Hagen; David R Jayne; J Charles Jennette; Kensuke Joh; Irmgard Neumann; Laure-Hélène Noël; Charles D Pusey; Rüdiger Waldherr; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

6.  Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center.

Authors:  Dong-yuan Chang; Li-hua Wu; Gang Liu; Min Chen; Cees G M Kallenberg; Ming-hui Zhao
Journal:  Nephrol Dial Transplant       Date:  2011-11-25       Impact factor: 5.992

Review 7.  Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Authors:  C Mukhtyar; O Flossmann; B Hellmich; P Bacon; M Cid; J W Cohen-Tervaert; W L Gross; L Guillevin; D Jayne; A Mahr; P A Merkel; H Raspe; D Scott; J Witter; H Yazici; R A Luqmani
Journal:  Ann Rheum Dis       Date:  2007-10-02       Impact factor: 19.103

8.  Estimating renal survival using the ANCA-associated GN classification.

Authors:  Marc Hilhorst; Benjamin Wilde; Peter van Breda Vriesman; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

Review 9.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

10.  Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.

Authors:  Sanjeevan Sriskandarajah; Knut Aasarød; Steinar Skrede; Thomas Knoop; Anna Varberg Reisæter; Rune Bjørneklett
Journal:  Nephrol Dial Transplant       Date:  2015-02-17       Impact factor: 5.992

View more
  5 in total

1.  Male Sex Is a Significant Predictor of All-cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Authors:  Hyeok Chan Kwon; Jung Yoon Pyo; Lucy Eunju Lee; Sung Soo Ahn; Jason Jungsik Song; Yong Beom Park; Sang Won Lee
Journal:  J Korean Med Sci       Date:  2021-05-10       Impact factor: 2.153

2.  Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study.

Authors:  Anna Salmela; Tom Törnroth; Tuija Poussa; Agneta Ekstrand
Journal:  Int J Nephrol       Date:  2018-10-16

3.  Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.

Authors:  Désirée Tampe; Peter Korsten; Philipp Ströbel; Samy Hakroush; Björn Tampe
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

4.  Relationship Between Gender and 1-Year Mortality in ANCA-Associated Vasculitis Patients: A Single-Center Retrospective Analysis and Meta-Analysis.

Authors:  Qing Zhu; Fen Li; Xi Xie; Bilin Chen; Qianwen Yu; Yusong Wei; Yan Ge
Journal:  Front Med (Lausanne)       Date:  2022-07-13

5.  A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes.

Authors:  Jennifer Scott; Carolina Canepa; Antonia Buettner; Louise Ryan; Bróna Moloney; Sarah Cormican; Cathal Walsh; Arthur White; Alan D Salama; Mark A Little
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.